Neil Dunavin, MD, MS, discusses ongoing research on therapies for patients with myelofibrosis.
Neil Dunavin, MD, MS
Advertisement
Articles by Neil Dunavin, MD, MS
Neil Dunavin, MD, MS, discusses frontline treatment in myelofibrosis.
Neil Dunavin, MD, MS, assistant professor of medicine, School of Medicine, University of California, San Francisco (UCSF), UCSF Helen Diller Family Comprehensive Cancer Center, discusses treatment considerations in myelofibrosis.
Advertisement
Latest Updated Articles
Dr. Dunavin on Treatment Considerations in MyelofibrosisJanuary 10th 2020
Dr. Dunavin on Frontline Treatment in MyelofibrosisJanuary 20th 2020
Dr. Dunavin on Ongoing Research for Myelofibrosis TreatmentsJanuary 27th 2020
Advertisement
Advertisement
Trending on OncLive
1
ctDNA Status Has Strong Prognostic Value, Outperforming pCR Status, in Early TNBC
2
The OncFive: Top Oncology Articles for the Week of 5/31
3
From Toilet Cleaner to Thoracic Oncologist and Patient: How Ross Camidge Built a Life Worth Loving
4
Breast Cancer Experts Spotlight Practice-Informing and Thought-Provoking Data From ASCO 2026
5